Literature DB >> 3843570

Clinical aspects of virus/immune myocarditis.

J B O'Connell, J A Robinson, R M Gunnar, P J Scanlon.   

Abstract

Although a cause-and-effect relationship between viral infection and myocarditis remains inferential, two distinct clinical syndromes can be identified. During the early viral phase, the cardiac manifestations emerge while the symptoms of active viral infection are also present. During the chronic phase, symptoms of the viral infection may be remote or nonexistent, and identification of active myocarditis is contingent upon an aggressive diagnostic approach with endomyocardial biopsy and gallium 67 imaging. The exact incidence of myocarditis in patients with heart failure of unknown cause is unclear due to lack of standardization of histologic parameters. There are no other clinical clues to the presence of myocarditis in those patients presenting with cardiomyopathy or ventricular arrhythmia. For further clarification of the incidence and various presentations of myocarditis a large multi-center trial is necessary.

Entities:  

Mesh:

Year:  1985        PMID: 3843570      PMCID: PMC7088165          DOI: 10.1007/bf02072373

Source DB:  PubMed          Journal:  Heart Vessels Suppl        ISSN: 0935-736X


  66 in total

1.  Gallium-67 imaging in cardiomyopathy.

Authors:  J A Robinson; J O'Connell; R E Henkin; R M Gunnar
Journal:  Ann Intern Med       Date:  1979-02       Impact factor: 25.391

2.  The role of Coxsackie group B virus infections in sporadic myopericarditis.

Authors:  C H Koontz; C G Ray
Journal:  Am Heart J       Date:  1971-12       Impact factor: 4.749

3.  Coxsackie B myopericarditis in adults.

Authors:  W G Smith
Journal:  Am Heart J       Date:  1970-07       Impact factor: 4.749

4.  Residual pathologic changes following murine coxsackie A and B myocarditis.

Authors:  F M Wilson; Q R Miranda; J L Chason; A M Lerner
Journal:  Am J Pathol       Date:  1969-05       Impact factor: 4.307

5.  Myocardial involvement in Rocky Mountain spotted fever.

Authors:  W D Bradford; D B Hackel
Journal:  Arch Pathol Lab Med       Date:  1978-07       Impact factor: 5.534

6.  Myopericarditis associated with ECHO virus type 3 infection--A case report.

Authors:  T Fukuhara; M Kinoshita; K Bito; M Sawamura; M Motomura; S Kawakita; K Kawanishi
Journal:  Jpn Circ J       Date:  1983-11

7.  Pathogenesis of myocarditis in Rocky Mountain spotted fever.

Authors:  D H Walker; C E Paletta; B G Cain
Journal:  Arch Pathol Lab Med       Date:  1980-04       Impact factor: 5.534

8.  Peripartum cardiomyopathy due to myocarditis.

Authors:  K R Melvin; P J Richardson; E G Olsen; K Daly; G Jackson
Journal:  N Engl J Med       Date:  1982-09-16       Impact factor: 91.245

9.  Myocardial damage in viral hemorrhagic fevers.

Authors:  J Milei; N J Bolomo
Journal:  Am Heart J       Date:  1982-12       Impact factor: 4.749

10.  Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. II. Myocarditis.

Authors:  M Sekiguchi; M Hiroe; M Take; K Hirosawa
Journal:  Jpn Circ J       Date:  1980-04
View more
  3 in total

Review 1.  Therapeutic implications of immune mechanisms in myocarditis.

Authors:  J B O'Connell; J W Mason
Journal:  Springer Semin Immunopathol       Date:  1989

Review 2.  Diagnosing and treating active myocarditis.

Authors:  J B O'Connell; J W Mason
Journal:  West J Med       Date:  1989-04

3.  Prognosis and treatment of cardiomyopathy and myocarditis.

Authors:  J B O'Connell; M R Costanzo-Nordin; R S Engelmeier; D E Wallis; J A Robinson; P J Scanlon
Journal:  Heart Vessels Suppl       Date:  1985
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.